Denice Torres
Insider Reports History
- Location
- New Hope, PA
- Signature
- Diana Scherer, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Denice Torres:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GLAUKOS Corp | Director | Common Stock | 22,334 | $2,521,734 | $112.91 | 02 Jan 2026 | Direct |
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 24,100 | $94,713 | $3.93 | 10 Jun 2024 | Direct |
| GLAUKOS Corp | Director | Stock Option (Right to Buy) | 3,149 | $86,348 | $69.30 | 29 May 2025 | Direct |
| bluebird bio, Inc. | Director | Common Stock | 2,726 | $3,897 | $1.43 | 11 Nov 2021 | Direct |
| 2seventy bio, Inc. | Director | Common Stock | 0 | $0 | $4.94 | 13 May 2025 | Direct |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Direct |
| Karuna Therapeutics, Inc. | Director | Option (right to buy) | 0 | $0 | $92.30 | 18 Mar 2024 | Direct |
| Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 33,000 | 05 Jun 2025 | Direct | ||
| Surface Oncology, Inc. | Director | Stock Option (Right to Buy) | 24,000 | 08 Jun 2022 | Direct | ||
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 0 | 13 May 2025 | Direct | ||
| bluebird bio, Inc. | Director | Stock Option (right to buy) | 0 | 11 Nov 2021 | Direct |